Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/spandidos-publications/igf-axis-and-other-factors-in-hpv-related-and-hpv-unrelated-5b6x80xF5w
References (130)
-
J. Doorbar (2006)
Molecular biology of human papillomavirus infection and cervical cancer.Clinical science, 110 5
-
J. Guevara-Aguirre, P. Balasubramanian, M. Guevara-Aguirre, Min Wei, F. Madia, Chia-Wei Cheng, David Hwang, Alejandro Martín-Montalvo, Jannette Saavedra, S. Ingles, R. Cabo, P. Cohen, V. Longo (2011)
Growth Hormone Receptor Deficiency Is Associated with a Major Reduction in Pro-Aging Signaling, Cancer, and Diabetes in HumansScience Translational Medicine, 3
-
Lesley Breech, P. Braverman
International Journal of Women's Health Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article -
Lina Sun, Ge Zhang, T. Lei, Chen Huang, T. Song, L. Si (2008)
Two different HPV-11E6 fusion proteins trap p53 in the cytoplasm and induce apoptosisCancer Biology & Therapy, 7
-
M. Doeberitz (2002)
New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections.European journal of cancer, 38 17
-
LeRoith (2003)
The insulin-like growth factor system and cancerCancer Lett, 195
-
J. Cheung, T. Cheung, Mei-yung Yu, P. Chan (2013)
Virological characteristics of cervical cancers carrying pure episomal form of HPV16 genome.Gynecologic oncology, 131 2
-
M. Serrano, M. Sanchez-Gomez, M. Bravo, S. Yakar, D. Leroith (2008)
Differential Expression of IGF-I and Insulin Receptor Isoforms in HPV Positive and Negative Human Cervical Cancer Cell LinesHormone and Metabolic Research, 40
-
Jiang Hong, George Zhang, F. Dong, M. Rechler (2002)
Insulin-like Growth Factor (IGF)-binding Protein-3 Mutants That Do Not Bind IGF-I or IGF-II Stimulate Apoptosis in Human Prostate Cancer Cells*The Journal of Biological Chemistry, 277
-
H. Kuramoto, A. Hongo, Yi-xuan Liu, Y. Ojima, K. Nakamura, N. Seki, J. Kodama, Y. Hiramatsu (2008)
Immunohistochemical evaluation of insulin-like growth factor I receptor status in cervical cancer specimens.Acta medica Okayama, 62 4
-
S. Rosenzweig, H. Atreya (2010)
Defining the pathway to insulin-like growth factor system targeting in cancer.Biochemical pharmacology, 80 8
-
K. Reiss, K. Khalili, A. Giordano, J. Trojanek (2006)
JC virus large T‐antigen and IGF‐I signaling system merge to affect DNA repair and genomic integrityJournal of Cellular Physiology, 206
-
B. Mannhardt, S. Weinzimer, M. Wagner, M. Fiedler, P. Cohen, P. Jansen-Dürr, W. Zwerschke (2000)
Human Papillomavirus Type 16 E7 Oncoprotein Binds and Inactivates Growth-Inhibitory Insulin-Like Growth Factor Binding Protein 3Molecular and Cellular Biology, 20
-
H. Hartog, J. Wesseling, H. Boezen, W. Graaf (2007)
The insulin-like growth factor 1 receptor in cancer: old focus, new future.European journal of cancer, 43 13
-
R. Watson, Miranda Thomas, L. Banks, S. Roberts (2003)
Activity of the human papillomavirus E6 PDZ-binding motif correlates with an enhanced morphological transformation of immortalized human keratinocytesJournal of Cell Science, 116
-
Xifeng Wu, G. Tortolero-Luna, Hua Zhao, Deepali Phatak, M. Spitz, M. Follen (2003)
Serum levels of insulin-like growth factor I and risk of squamous intraepithelial lesions of the cervix.Clinical cancer research : an official journal of the American Association for Cancer Research, 9 9
-
A. Grimberg (2003)
Mechanisms by which IGF-I May Promote CancerCancer Biology & Therapy, 2
-
Tiffany Harris, R. Burk, Herbert Yu, H. Minkoff, L. Massad, D. Watts, Y. Zhong, S. Gange, R. Kaplan, K. Anastos, A. Levine, M. Moxley, X. Xue, M. Fazzari, J. Palefsky, H. Strickler (2008)
Insulin-Like Growth Factor Axis and Oncogenic Human Papillomavirus Natural HistoryCancer Epidemiology Biomarkers & Prevention, 17
-
J. Doorbar, W. Quint, L. Banks, I. Bravo, M. Stoler, T. Broker, M. Stanley (2012)
The biology and life-cycle of human papillomaviruses.Vaccine, 30 Suppl 5
-
L. Goetsch, N. Corvaïa (2009)
Insulin-like growth factor receptor type I as a target for cancer therapy.Immunotherapy, 1 2
-
B. Miller, D. Yee (2005)
Type I insulin-like growth factor receptor as a therapeutic target in cancer.Cancer research, 65 22
-
M. Tommasino, R. Accardi, S. Caldeira, W. Dong, I. Malanchi, A. Smet, I. Zehbe (2003)
The role of TP53 in Cervical carcinogenesisHuman Mutation, 21
-
K. Han, J. Sin (2013)
DNA vaccines targeting human papillomavirus-associated diseases: progresses in animal and clinical studiesClinical and Experimental Vaccine Research, 2
-
T. Yugawa, T. Kiyono (2009)
Molecular mechanisms of cervical carcinogenesis by high‐risk human papillomaviruses: novel functions of E6 and E7 oncoproteinsReviews in Medical Virology, 19
-
Martin Whiteside, Erin Siegel, Elizabeth Unger (2008)
Human papillomavirus and molecular considerations for cancer riskCancer, 113
-
D. Silva, J. Schiller, W. Kast (2003)
Heterologous boosting increases immunogenicity of chimeric papillomavirus virus-like particle vaccines.Vaccine, 21 23
-
D. Tan, Alexandra Cook, S. Chew (2002)
Nucleolar localization of an isoform of the IGF-I precursorBMC Cell Biology, 3
-
S. Peng, H. Ji, C. Trimble, Liangmei He, Y. Tsai, Jessica Yeatermeyer, David Boyd, C. Hung, T. Wu (2004)
Development of a DNA Vaccine Targeting Human Papillomavirus Type 16 Oncoprotein E6Journal of Virology, 78
-
M. Pollak (2012)
The Insulin Receptor/Insulin-Like Growth Factor Receptor Family as a Therapeutic Target in OncologyClinical Cancer Research, 18
-
P. Gariglio, J. Gutiérrez, E. Cortés, J. Vázquez (2009)
The role of retinoid deficiency and estrogens as cofactors in cervical cancer.Archives of medical research, 40 6
-
Rachel Steuerman, O. Shevah, Z. Laron, (2011)
Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies.European journal of endocrinology, 164 4
-
S. Vinokurova, N. Wentzensen, I. Kraus, R. Klaes, Corina Driesch, P. Melsheimer, F. Kisseljov, M. Dürst, A. Schneider, M. Doeberitz (2008)
Type-dependent integration frequency of human papillomavirus genomes in cervical lesions.Cancer research, 68 1
-
M. Serrano, A. Romero, R. Cendales, M. Sanchez-Gomez, M. Bravo (2006)
Serum levels of insulin-like growth factor-I and -II and insulin-like growth factor binding protein 3 in women with squamous intraepithelial lesions and cervical cancer.Biomedica : revista del Instituto Nacional de Salud, 26 2
-
K. Butz, T. Ristriani, Arnd Hengstermann, C. Denk, M. Scheffner, F. Hoppe-Seyler (2003)
siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cellsOncogene, 22
-
A. Lukanova, E. Lundin, P. Toniolo, A. Micheli, A. Akhmedkhanov, S. Rinaldi, P. Muti, P. Lenner, C. Biessy, V. Krogh, A. Zeleniuch‐Jacquotte, F. Berrino, G. Hallmans, E. Riboli, R. Kaaks (2002)
Circulating levels of insulin‐like growth factor‐I and risk of ovarian cancerInternational Journal of Cancer, 101
-
H. Jo, J. Kim (2005)
Implications of HPV infection in uterine cervical cancerArticle -
Margaret McLaughlin-Drubin, Jordan Meyers, K. Munger (2012)
Cancer associated human papillomaviruses.Current opinion in virology, 2 4
-
N. Ganguly, S. Parihar (2009)
Human papillomavirus E6 and E7 oncoproteins as risk factors for tumorigenesisJournal of Biosciences, 34
-
Corvaia (2013)
Insulin-like growth factor receptor type I as a target for cancer therapyFront Biosci, 5
-
V. Wilson, M. West, K. Woytek, D. Rangasamy (2002)
Papillomavirus E1 Proteins: Form, Function, and FeaturesVirus Genes, 24
-
E. Thorland, Shannon Myers, B. Gostout, David Smith (2003)
Common fragile sites are preferential targets for HPV16 integrations in cervical tumorsOncogene, 22
-
L. Maso, L. Augustin, S. Franceschi, R. Talamini, J. Polesel, C. Kendall, D. Jenkins, E. Vidgen, C. Vecchia (2004)
Association between Components of the Insulin-Like Growth Factor System and Epithelial Ovarian Cancer RiskOncology, 67
-
Wenyi Gu, L. Putral, K. Hengst, K. Minto, Nicholas Saunders, G. Leggatt, N. McMillan (2006)
Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenesCancer Gene Therapy, 13
-
M. Koczorowska, A. Kwaśniewska, A. Gozdzicka-Jozefiak (2011)
IGF1 mRNA isoform expression in the cervix of HPV-positive women with pre-cancerous and cancer lesions.Experimental and therapeutic medicine, 2 1
-
R. Ghittoni, R. Accardi, U. Hasan, T. Gheit, B. Sylla, M. Tommasino (2010)
The biological properties of E6 and E7 oncoproteins from human papillomavirusesVirus Genes, 40
-
A. Schaffer, A. Koushik, H. Trottier, E. Duarte‐Franco, N. Mansour, J. Arseneau, D. Provencher, L. Gilbert, W. Gotlieb, A. Ferenczy, F. Coutlée, M. Pollak, E. Franco (2007)
Insulin-like Growth Factor-I and Risk of High-Grade Cervical Intraepithelial NeoplasiaCancer Epidemiology Biomarkers & Prevention, 16
-
R. Baserga (2013)
The decline and fall of the IGF‐I receptorJournal of Cellular Physiology, 228
-
J. Durzynska, A. Philippou, Becky Brisson, Michelle Nguyen-McCarty, E. Barton (2013)
The pro-forms of insulin-like growth factor I (IGF-I) are predominant in skeletal muscle and alter IGF-I receptor activation.Endocrinology, 154 3
-
E. Villiers, C. Fauquet, T. Broker, H. Bernard, H. Hausen (2004)
Classification of papillomaviruses.Virology, 324 1
-
A. Kasprzak, Witold Szaflarski, J. Szmeja, Małgorzata Andrzejewska, W. Przybyszewska, E. Kaczmarek, M. Koczorowska, T. Kościński, M. Zabel, M. Drews (2012)
Differential expression of IGF-1 mRNA isoforms in colorectal carcinoma and normal colon tissue.International journal of oncology, 42 1
-
Z. Laron, (2004)
Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958-2003.The Journal of clinical endocrinology and metabolism, 89 3
-
H. Hausen (2002)
Papillomaviruses and cancer: from basic studies to clinical applicationNature Reviews Cancer, 2
-
T. Brake, P. Lambert (2005)
Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model.Proceedings of the National Academy of Sciences of the United States of America, 102 7
-
A. Psyrri, D. DiMaio (2008)
Human papillomavirus in cervical and head-and-neck cancerNature Clinical Practice Oncology, 5
-
E. Copreni, Marianna Penzo, Salvatore Carrabino, Massimo Conese (2004)
Lentivirus-mediated gene transfer to the respiratory epithelium: a promising approach to gene therapy of cystic fibrosisGene Therapy, 11
-
M. Serrano, M. Sanchez-Gomez, M. Bravo (2010)
Cervical scrapes levels of insulin-like growth factor-II and insulin-like growth factor binding protein 3 in women with squamous intraepithelial lesions and cervical cancer.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 42 13
-
M. Steller, C. Delgado, C. Bartels, C. Woodworth, Z. Zou (1996)
Overexpression of the insulin-like growth factor-1 receptor and autocrine stimulation in human cervical cancer cells.Cancer research, 56 8
-
E. Gallagher, D. Leroith (2011)
Minireview: IGF, Insulin, and Cancer.Endocrinology, 152 7
-
A. Samani, S. Yakar, D. Leroith, P. Brodt (2007)
The role of the IGF system in cancer growth and metastasis: overview and recent insights.Endocrine reviews, 28 1
-
Jiansong Zhou, Baohua Li, Chanjuan Peng, Fenfen Wang, Zhi-qin Fu, Cai-yun Zhou, Die Hong, F. Ye, W. Lü, Xing Xie (2013)
Inhibition of cervical cancer cell growth in vitro and in vivo by lentiviral-vector mediated shRNA targeting the common promoter of HPV16 E6 and E7 oncogenes.Antiviral research, 98 2
-
T. Aleksic, M. Chitnis, O. Perestenko, Shan Gao, Peter Thomas, G. Turner, A. Protheroe, M. Howarth, V. Macaulay (2010)
Type 1 insulin-like growth factor receptor translocates to the nucleus of human tumor cells.Cancer research, 70 16
-
J. Trojanek, S. Croul, T. Ho, Jin Wang, A. Darbinyan, M. Nowicki, L. Valle, T. Skorski, K. Khalili, K. Reiss (2006)
T‐antigen of the human polyomavirus JC attenuates faithful DNA repair by forcing nuclear interaction between IRS‐1 and Rad51Journal of Cellular Physiology, 206
-
G. Loughran, M. Huigsloot, P. Kiely, Loraine Smith, Suzanne Floyd, V. Ayllón, R. O’Connor (2005)
Gene expression profiles in cells transformed by overexpression of the IGF-I receptorOncogene, 24
-
C. Sell, M. Rubini, R. Rubin, Jeh-Ping Liu, A. Efstratiadis, R. Baserga (1993)
Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor.Proceedings of the National Academy of Sciences of the United States of America, 90 23
-
A. Kędzia, J. Durzynska, Bartosz Gabryelczyk, E. Petriczko, A. Gozdzicka-Jozefiak (2013)
An analysis of the IGF-I receptor coding sequence in the genome of children with growth disorders.Pediatric endocrinology, diabetes, and metabolism, 19 3
-
P. Berraondo, C. Nouze, X. Preville, D. Ladant, C. Leclerc (2007)
Eradication of large tumors in mice by a tritherapy targeting the innate, adaptive, and regulatory components of the immune system.Cancer research, 67 18
-
Jo (2005)
Implications of HPV infection in uterine cervical cancerCancer Ther, 3
-
Y-F Huang, M. Shen, K. Hsu, Y.‐M. Cheng, C. Chou (2008)
Clinical implications of insulin-like growth factor 1 system in early-stage cervical cancerBritish Journal of Cancer, 99
-
Annie Chandy, M. Nurkkala, A. Josefsson, K. Eriksson (2007)
Therapeutic dendritic cell vaccination with Ag coupled to cholera toxin in combination with intratumoural CpG injection leads to complete tumour eradication in mice bearing HPV 16 expressing tumours.Vaccine, 25 32
-
R. Mathur, S. Mathur (2003)
In vitro downregulation of growth factors by insulin-like growth factor binding protein-3 in cervical cancer.Gynecologic oncology, 91 2
-
Y. Yoo, Jieun Son, F. Mehta, F. DeMayo, J. Lydon, S. Chung (2013)
Progesterone signaling inhibits cervical carcinogenesis in mice.The American journal of pathology, 183 5
-
Hyun-Sun Jin, Eun Park, J. Lee, S. Namkoong, Do-Gang Kim, Young-Joo Lee, Heung-Jae Jun, B. Han, S. Bae, W. Ahn (2005)
Immunization with adenoviral vectors carrying recombinant IL-12 and E7 enhanced the antitumor immunity to human papillomavirus 16-associated tumor.Gynecologic oncology, 97 2
-
S. Chung, S. Franceschi, P. Lambert (2010)
Estrogen and ERα: Culprits in cervical cancer?Trends in Endocrinology & Metabolism, 21
-
G. Clifford, Jennifer Smith, M. Plummer, N. Muñoz, S. Franceschi (2003)
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysisBritish Journal of Cancer, 88
-
P. Mullis (2010)
Genetics of isolated growth hormone deficiency.Journal of clinical research in pediatric endocrinology, 2 2
-
Ricardo López-Romero, E. Garrido‐Guerrero, Angélica Rangel-López, L. Manuel-Apolinar, P. Piña-Sánchez, M. Lazos-Ochoa, A. Mantilla-Morales, C. Bandala, M. Salcedo (2013)
The cervical malignant cells display a down regulation of ER-α but retain the ER-β expression.International journal of clinical and experimental pathology, 6 8
-
R. Baserga (2009)
The insulin receptor substrate-1: a biomarker for cancer?Experimental cell research, 315 5
-
K. Nakamura, A. Hongo, J. Kodama, Y. Miyagi, M. Yoshinouchi, T. Kudo (2000)
Down-regulation of the insulin-like growth factor I receptor by antisense RNA can reverse the transformed phenotype of human cervical cancer cell lines.Cancer research, 60 3
-
D. Voskuil, A. Bosma, A. Vrieling, M. Rookus, L. Veer (2004)
Insulin-Like Growth Factor (IGF)-System mRNA Quantities in Normal and Tumor Breast Tissue of Women with Sporadic and Familial Breast Cancer RiskBreast Cancer Research and Treatment, 84
-
Weizhu Zhu, Wenyi Qin, P. Bradley, A. Wessel, C. Puckett, E. Sauter (2004)
Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid.Carcinogenesis, 26 1
-
J. Siegfried, P. Kasprzyk, A. Treston, J. Mulshine, K. Quinn, F. Cuttitta (1992)
A mitogenic peptide amide encoded within the E peptide domain of the insulin-like growth factor IB prohormone.Proceedings of the National Academy of Sciences of the United States of America, 89 17
-
Allison Hall, K. Alexander (2003)
RNA Interference of Human Papillomavirus Type 18 E6 and E7 Induces Senescence in HeLa CellsJournal of Virology, 77
-
K. Webster, Anna Taylor, K. Gaston (2001)
Oestrogen and progesterone increase the levels of apoptosis induced by the human papillomavirus type 16 E2 and E7 proteins.The Journal of general virology, 82 Pt 1
-
A. Baege, G. Disbrow, R. Schlegel (2004)
IGFBP-3, a Marker of Cellular Senescence, Is Overexpressed in Human Papillomavirus-Immortalized Cervical Cells and Enhances IGF-1-Induced MitogenesisJournal of Virology, 78
-
S. Ramamoorthy, B. Devaraj, K. Miyai, L. Luo, Yu-Tseung Liu, C. Boland, A. Goel, J. Carethers (2011)
John Cunningham virus T‐antigen expression in anal carcinomaCancer, 117
-
T. Kafri, H. Praag, F. Gage, Inder Verma (2000)
Lentiviral vectors: regulated gene expression.Molecular therapy : the journal of the American Society of Gene Therapy, 1 6
-
J. Durzynska, J. Durzynska, A. Wardzinski, M. Koczorowska, A. Gozdzicka-Jozefiak, E. Barton (2013)
Human Eb Peptide: Not just a By-product of Pre-pro-IGF1b Processing?Hormone and Metabolic Research, 45
-
T. Cheung, K. Man, Mei-yung Yu, S. Yim, N. Siu, K. Lo, G. Doran, R. Wong, V. Wang, David Smith, Michael Jr., R. Berkowitz, T. Chung, Y. Wong (2012)
Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasmCell Cycle, 11
-
G. Gunn, A. Zubair, C. Peters, Z. Pan, T. Wu, Y. Paterson (2001)
Two Listeria monocytogenes Vaccine Vectors That Express Different Molecular Forms of Human Papilloma Virus-16 (HPV-16) E7 Induce Qualitatively Different T Cell Immunity That Correlates with Their Ability to Induce Regression of Established Tumors Immortalized by HPV-161The Journal of Immunology, 167
-
A. Kasprzak, Witold Szaflarski, J. Szmeja, Małgorzata Andrzejewska, W. Przybyszewska, M. Koczorowska, M. Drews, E. Kaczmarek (2012)
Expression of various insulin-like growth factor-1 mRNA isoforms in colorectal cancerContemporary Oncology, 16
-
R. Friedrich, C. Hagel, S. Bartel-Friedrich (2010)
Insulin-like growth factor-1 receptor (IGF-1R) in primary and metastatic undifferentiated carcinoma of the head and neck: a possible target of immunotherapy.Anticancer research, 30 5
-
C. Piyathilake, O. Henao, M. Macaluso, P. Cornwell, S. Meleth, D. Heimburger, E. Partridge (2004)
Folate Is Associated with the Natural History of High-Risk Human PapillomavirusesCancer Research, 64
-
L. Markowitz, V. Tsu, S. Deeks, H. Cubie, S. Wang, A. Vicari, J. Brotherton (2012)
Human papillomavirus vaccine introduction--the first five years.Vaccine, 30 Suppl 5
-
B. Forbes (2011)
Molecular mechanisms underlying insulin-like growth factor action: How mutations in the GH: IGF axis lead to short stature.Pediatric endocrinology reviews : PER, 8 4
-
H. Hausen (2009)
Papillomaviruses in the causation of human cancers - a brief historical account.Virology, 384 2
-
K. Egawa (2003)
Do Human Papillomaviruses Target Epidermal Stem Cells?Dermatology, 207
-
M. Shen, Yueh-Mei Hsu, K. Hsu, Yih-Fung Chen, M. Tang, C. Chou (2006)
Insulin-like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by alphavbeta3 integrin signaling.Carcinogenesis, 27 5
-
Jianxin You, Jennie Croyle, A. Nishimura, K. Ozato, P. Howley (2004)
Interaction of the Bovine Papillomavirus E2 Protein with Brd4 Tethers the Viral DNA to Host Mitotic ChromosomesCell, 117
-
I. Frazer (2004)
Prevention of cervical cancer through papillomavirus vaccinationNature Reviews Immunology, 4
-
A. Berger, A. Baege, Tracy Guillemette, J. Deeds, R. Meyer, G. Disbrow, R. Schlegel, R. Schlegel (2002)
Insulin-like growth factor-binding protein 3 expression increases during immortalization of cervical keratinocytes by human papillomavirus type 16 E6 and E7 proteins.The American journal of pathology, 161 2
-
J. Doorbar (2005)
The papillomavirus life cycle.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 32 Suppl 1
-
Jin-hui Gao, Yong Chang, B. Jallal, J. Viner (2012)
Targeting the insulin-like growth factor axis for the development of novel therapeutics in oncology.Cancer research, 72 1
-
H. Bernard (2005)
The clinical importance of the nomenclature, evolution and taxonomy of human papillomavirusesJournal of Clinical Virology, 32
-
Margaret McLaughlin-Drubin, K. Münger (2009)
The human papillomavirus E7 oncoprotein.Virology, 384 2
-
A. Kasprzak, A. Adamek (2012)
The insulin-like growth factor (IGF) signaling axis and hepatitis C virus-associated carcinogenesis (review).International journal of oncology, 41 6
-
M. Shen, Yueh-Mei Hsu, K. Hsu, Yih-Fung Chen, M. Tang, C. Chou (2006)
Insulin-like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by αvβ3 integrin signalingCarcinogenesis, 27
-
E. Martignani, S. Miretti, P. Accornero, M. Baratta (2011)
miRNAs highlights in stem and cancer cells.Mini reviews in medicinal chemistry, 11 13
-
E. Pietsch, M. Murphy (2008)
Low risk HPV-E6 traps p53 in the cytoplasm and induces p53-dependent apoptosisCancer Biology & Therapy, 7
-
SiWon Lee, Soo Lee, S. Lee, W. Ju, Seung Kim (2010)
Plasma levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in women with cervical neoplasia.Journal of gynecologic oncology, 21 3
-
S. Mathur, R. Mathur, P. Underwood, M. Kohler, W. Creasman (2003)
Circulating levels of insulin-like growth factor-II and IGF-binding protein 3 in cervical cancer.Gynecologic oncology, 91 3
-
Z. Laron, (2008)
The GH-IGF1 axis and longevity. The paradigm of IGF1 deficiencyHormones, 7
-
A. Warowicka, A. Kwaśniewska, A. Gozdzicka-Jozefiak (2013)
Alterations in mtDNA: a qualitative and quantitative study associated with cervical cancer development.Gynecologic oncology, 129 1
-
W. Guo, Denghua Yang, Hongbo Xu, Yang Zhang, Junwei Huang, Zheng Yang, Xiaohong Chen, Zhigang Huang (2012)
Mutations in the D-loop region and increased copy number of mitochondrial DNA in human laryngeal squamous cell carcinomaMolecular Biology Reports, 40
-
Anny Shai, T. Brake, C. Somoza, P. Lambert (2007)
The human papillomavirus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activities.Cancer research, 67 4
-
L. Bousarghin, A. Touzé, G. Gaud, S. Iochmann, E. Alvarez, P. Reverdiau, J. Gaitan, M. Jourdan, P. Sizaret, P. Coursaget (2009)
Inhibition of cervical cancer cell growth by human papillomavirus virus–like particles packaged with human papillomavirus oncoprotein short hairpin RNAsMolecular Cancer Therapeutics, 8
-
Min Luo, Dong-xiang Shen, Xiaoning Zhou, Xiaodong Chen, Wei Wang (2013)
MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.Surgery, 153 6
-
R. DePinho (2000)
The age of cancerNature, 408
-
H. Hausen (2000)
Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in CarcinogenesisJournal of the National Cancer Institute, 92
-
E. Petriczko, B. Wikiera, A. Horodnicka-Józwa, K. Marcinkiewicz, Justyna Szmit-Domagalska, A. Kędzia, J. Durzynska, J. Broniarczyk, Bartosz Gabryelczyk, A. Noczyńska, M. Walczak (2011)
A two year observation of the process of applying recombinant IGF-1 to treat short stature in children with primary IGF-1 deficiency -- case reports of 3 patients.Pediatric endocrinology, diabetes, and metabolism, 17 4
-
Piyathilake (2010)
Indian women with higher serum concentrations of folate and vitamin B12 are significantly less likely to be infected with carcinogenic or high-risk (HR) types of human papillomaviruses (HPVs)Int J Womens Health, 2
-
M. Pollak (2008)
Insulin and insulin-like growth factor signalling in neoplasiaNature Reviews Cancer, 8
-
E. Barton (2006)
The ABCs of IGF-I isoforms: impact on muscle hypertrophy and implications for repair.Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme, 31 6
-
Christelle Remy-Ziller, C. Germain, Anita Spindler, C. Hoffmann, N. Silvestre, R. Rooke, J. Bonnefoy, X. Preville (2013)
Immunological Characterization of a Modified Vaccinia Virus Ankara Vector Expressing the Human Papillomavirus 16 E1 ProteinClinical and Vaccine Immunology, 21
-
A. Arcaro (2013)
Targeting the insulin-like growth factor-1 receptor in human cancerFrontiers in Pharmacology, 4
-
M. Sharma, A. Satyam, A. Abhishek, R. Khan, M. Rajappa, Alpana Sharma (2012)
Molecular and circulatory expression of insulin growth factors in Indian females with advanced cervical cancer.Asian Pacific journal of cancer prevention : APJCP, 13 12
-
S. Wang, H. Carmichael, Shayne Andrew, Timothy Miller, Jennifer Moon, Michael Derr, V. Hwa, J. Hirschhorn, A. Dauber (2013)
Large-scale pooled next-generation sequencing of 1077 genes to identify genetic causes of short stature.The Journal of clinical endocrinology and metabolism, 98 8
-
Wei-Ming Wang, Min-Huey Chung, Shih-Ming Huang (2003)
Regulation of nuclear receptor activities by two human papillomavirus type 18 oncoproteins, E6 and E7.Biochemical and biophysical research communications, 303 3
-
M. Pollak, E. Schernhammer, S. Hankinson (2004)
Insulin-like growth factors and neoplasiaNature Reviews Cancer, 4
-
M. Serrano, M. Sanchez-Gomez, M. Bravo (2007)
Insulin-like growth factor system gene expression in cervical scrapes from women with squamous intraepithelial lesions and cervical cancer.Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 17 6
-
R. Baserga (2009)
Customizing the targeting of IGF-1 receptor.Future oncology, 5 1
- Publisher
- Spandidos Publications
- Copyright
- Copyright © Spandidos Publications
- ISSN
- 1021-335X
- eISSN
- 1791-2431
- DOI
- 10.3892/or.2014.3505
- pmid
- 25333772
- Publisher site
- See Article on Publisher Site
Abstract
The insulin-like growth factor (IGF) axis promotes the growth of cells, tissues and organs. IGF-1 is mainly produced in the liver but is also secreted from local tissues. In the circulation, IGF-1 is bound to insulin-like binding proteins (IGFBPs), and when released it activates the insulin-like growth factor receptor (IGF-1R). The signal is further transmitted by intracellular signaling pathways leading to gene expression that regulates, among others, cell proliferation and survival. This review presents the IGF axis in the context of cell transformation and cancer development. Aspects involving IGF-1 deficiency and protection from cancer are also briefly described. Furthermore, human papillomaviruses (HPVs) interplaying with IGF axis components in cervical cancer development are described. These small dsDNA viruses are divided into low-risk and high-risk HPVs with regard to the potency of their oncogenic actions; they mainly infect epithelial or mucosal cells. Special attention is drawn to expression of two major HPV oncogenes (E6 and E7) initiating and maintaining cervical carcinogenesis, which is a multistep and multifactorial process; therefore, involvement of additional factors such as mitochondrial DNA changes, sex hormones, retinoic and folic acids are also discussed. Finally, IGF axis components and HPV oncogenes as targets in anticancer treatment are presented which include IGF-1R downregulation, RNA interference and anti-HPV therapeutic vaccines. The review concludes that despite an enormous advancement in research on IGF and HPV-related cancers, more molecular studies and clinical trials are needed before commercialized therapies are widely available for oncology patients.
Journal
Oncology Reports – Spandidos Publications
Published: Dec 1, 2014